The Internationalization of the Japanese
Executive SummaryJapanese companies have historically had problems getting into the US market because their deal approach in the 1970s was not appropriate for developing drugs. Only TAP succeeded-overcoming many management obstacles.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.